日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The role of budget impact in reimbursement decisions in The Netherlands: interviews with decision-makers and pharmaceutical industry representatives

预算影响在荷兰报销决策中的作用:对决策者和制药行业代表的访谈

Reckers-Droog, Vivian; Enzing, Joost; Brouwer, Werner

The role of budget impact and its relationship with cost-effectiveness in reimbursement decisions on health technologies in the Netherlands

预算影响及其与成本效益在荷兰医疗技术报销决策中的关系

Reckers-Droog, Vivian; Enzing, Joost; Brouwer, Werner

Psychometric evaluation of the Mental Health Quality of Life (MHQoL) instrument in seven European countries

在七个欧洲国家对心理健康生活质量(MHQoL)量表进行心理测量学评估

Enzing, Joost J; van Krugten, Frédérique C W; Sabat, Iryna; Neumann-Böhme, Sebastian; Boer, Bert; Knies, Saskia; Brouwer, Werner B F

Do Health Technology Assessment organisations consider manufacturers' costs in relation to drug price? A study of reimbursement reports

卫生技术评估机构在制定药品价格时是否会考虑生产商的成本?一项关于报销报告的研究

Enzing, Joost J; Knies, Saskia; Engel, Jop; IJzerman, Maarten J; Sander, Beate; Vreman, Rick; Boer, Bert; Brouwer, Werner B F

Broadening the application of health technology assessment in the Netherlands: a worthwhile destination but not an easy ride?

扩大卫生技术评估在荷兰的应用范围:这是一个值得追求的目标,但并非易事?

Enzing, Joost J; Knies, Saskia; Boer, Bert; Brouwer, Werner B F